2026/04/14 更新

お知らせ

 

写真a

ミトマ リヨウ
三笘 良
MITOMA RYO
所属
九州大学病院 リハビリテーション科 助教
職名
助教

学位

  • 医学博士 ( 2025年9月 九州大学 )

論文

  • Abnormal spontaneous activity and rest-task shift in schizophrenia 査読 国際誌

    Mitoma, R; Tamura, S; Hirano, S; Sung, YB; Takai, Y; Mitsudo, T; Nakao, T; Onitsuka, T; Hirano, Y

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   79 ( 10 )   697 - 706   2025年10月   ISSN:1323-1316 eISSN:1440-1819

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Psychiatry and Clinical Neurosciences  

    Aims: Schizophrenia (SZ) is associated with abnormalities in both spontaneous and task-evoked neural oscillations, and growing evidence shows that shift patterns of oscillatory activity between resting and task states are also disturbed. However, no study has simultaneously examined the frequency- and state-specific characteristics of oscillatory deficits in SZ. Using an auditory steady-state response (ASSR) paradigm, we aimed to examine the differential sensitivity of oscillatory measures to SZ and to assess rest–task shifts across multiple frequency bands. Methods: We recorded resting-state activity and 40 Hz ASSR of 66 neurotypical controls (NC) and 68 SZ patients using electroencephalography (EEG). 40 Hz stimulus-evoked activity was measured using evoked power, phase-locking factor (PLF), and phase-locking angle, whereas multi-frequency (4–100 Hz) spontaneous activity during ASSR and resting states was assessed using induced and resting power. The state-dependent shifts in spontaneous activity between the resting and ASSR states were evaluated over a broad frequency range. Results: Both induced and resting power in the low-frequency range (4–10 Hz) were elevated over widespread regions in SZ patients relative to NC. Gamma-band (39–100 Hz) induced power then demonstrated excellent ability to discriminate between SZ and NC. In addition, SZ patients showed a reduced rest–task shift in the theta-beta band (5–23 Hz) spontaneous power, most pronounced in the alpha-band (8–13 Hz). Conclusion: The present study confirmed the utility of gamma-band induced power during ASSR stimulation for differentiating SZ patients from NC. Importantly, our results also highlight the pathophysiological significance of the reduced rest–task shift pattern of spontaneous activity mainly in the alpha-band in SZ patients.

    DOI: 10.1111/pcn.13880

    Web of Science

    Scopus

    PubMed

  • When ECT is not readily available: Pharmacological management of catatonia in a correctional medical facility in Japan 査読 国際誌

    Mitoma, R; Sawada, T

    ASIAN JOURNAL OF PSYCHIATRY   118   104890   2026年4月   ISSN:1876-2018 eISSN:1876-2026

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Asian Journal of Psychiatry  

    DOI: 10.1016/j.ajp.2026.104890

    Web of Science

    Scopus

    PubMed

  • A systematic review and meta-analysis of the auditory steady-state response in schizophrenia, bipolar disorder, and autism spectrum disorder 査読 国際誌

    Kinjo, M; Tamura, S; Sugiyama, S; van Weert, E; Oribe, N; Tsuchimoto, R; Mitoma, R; Takai, Y; Honda, S; Nakajima, S; Hirano, Y; Uhlhaas, PJ; Noda, Y

    MOLECULAR PSYCHIATRY   2026年2月   ISSN:1359-4184 eISSN:1476-5578

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Molecular Psychiatry  

    Background: The 40-Hz auditory steady-state response (ASSR) is a potential biomarker for schizophrenia (SZ), bipolar disorder (BD), and autism spectrum disorder (ASD). However, the specific differences in ASSR across these disorders remain unclear. Moreover, the neurophysiological characteristics of the stimulation frequency in ASSR have not been fully elucidated. Hence, we conducted meta-analyses to comprehensively analyze 20-Hz, 40-Hz, and 80-Hz ASSR in individuals with SZ, BD, and ASD. Methods: We included the studies published until January 2025, identified through a literature search in PubMed and the reference lists of relevant studies. We analyzed 52 studies, including 2116 patients with SZ, 271 individuals at clinical high-risk for psychosis (CHR-P), 110 first-degree relatives of patients with SZ (FDR-SZ), 294 patients with BD, 117 patients with ASD, and 2758 healthy controls (HC). Results: The analyses indicated pronounced reductions in power and inter-trial phase coherence (ITPC) of 40-Hz ASSR in SZ, BD, and power reduction in ASD compared with HC. In addition, reduced power and ITPC were also observed in 40-Hz ASSR in FDR-SZ but not in CHR-P. Power reductions in 80-Hz ASSR were noted in individuals with SZ, while ITPC of 20-Hz ASSR was reduced in the SZ group but not in the BD group. Conclusions: These findings indicate that 40-Hz ASSR serves as a potential biomarker for psychotic disorders, whereas deficits at 20 Hz and 80 Hz may be specific to schizophrenia, reflecting distinct neural dysfunctions across diagnostic categories. Further studies are warranted to confirm these results.

    DOI: 10.1038/s41380-026-03452-3

    Web of Science

    Scopus

    PubMed

  • Adjunctive brexpiprazole for treatment-resistant functional/ dissociative seizures 査読 国際誌

    Mitoma, R; Hirano, S; Nakao, T

    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY   132   161 - 162   2025年11月   ISSN:1059-1311 eISSN:1532-2688

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Seizure  

    DOI: 10.1016/j.seizure.2025.09.007

    Web of Science

    Scopus

    PubMed

  • Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution 査読 国際誌

    Tsugawa, S; Kimura, Y; Chikazoe, J; Abe, H; Arisawa, T; Hatano, M; Nakajima, W; Uchida, H; Miyazaki, T; Takada, Y; Sano, A; Nakano, K; Eiro, T; Suda, A; Asami, T; Hishimoto, A; Tani, H; Nagai, N; Koizumi, T; Nakajima, S; Kurokawa, S; Ohtani, Y; Takahashi, K; Kikuchi, Y; Yatomi, T; Mitoma, R; Tamura, S; Baba, S; Togao, O; Hirano, Y; Kosaka, H; Okazawa, H; Mimura, M; Takahashi, T

    FRONTIERS IN NEURAL CIRCUITS   19   1624179   2025年8月   ISSN:16625110 eISSN:1662-5110

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers in Neural Circuits  

    An accurate diagnostic method using biological indicators is critically needed for bipolar disorder (BD) and major depressive disorder (MDD). The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a crucial regulator of synaptic function, and its dysregulation may play a central role in the pathophysiology of psychiatric disorders. Our recently developed positron emission tomography (PET) tracer, [<sup>11</sup>C]K-2, enables the quantitative visualization of AMPAR distribution and is considered useful for characterizing synaptic phenotypes in patients with psychiatric disorders. This study aimed to develop a machine learning-based method to differentiate bipolar disorder from major depressive disorder using AMPAR density. Sixteen patients with BD and 27 patients with MDD, all in depressive episodes, underwent PET scans with [<sup>11</sup>C]K-2 and structural magnetic resonance imaging. AMPAR density was estimated using the standardized uptake value ratio from 30 to 50 min after tracer injection, normalized to whole brain radioactivity. A partial least squares model was trained to predict diagnoses based on AMPAR density, and its performance was evaluated using a leave-one-pair-out cross-validation. Significant differences in AMPAR density were observed in the parietal lobe, cerebellum, and frontal lobe, notably the dorsolateral prefrontal cortex between patients with BD and patients with MDD during a depressive episode. The model achieved an area under the curve of 0.80, sensitivity of 75.0%, and specificity of 77.8%. These findings suggest that AMPAR density measured with [<sup>11</sup>C]K-2 can effectively distinguish BD from MDD and may aid diagnosis, especially in patients with ambiguous symptoms or incomplete clinical presentation.

    DOI: 10.3389/fncir.2025.1624179

    Web of Science

    Scopus

    PubMed

  • Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography 査読 国際誌

    Hatano, M; Nakajima, W; Tani, H; Uchida, H; Miyazaki, T; Arisawa, T; Takada, Y; Tsugawa, S; Sano, A; Nakano, K; Eiro, T; Abe, H; Suda, A; Asami, T; Hishimoto, A; Nagai, N; Koizumi, T; Nakajima, S; Kurokawa, S; Ohtani, Y; Takahashi, K; Kikuchi, Y; Yatomi, T; Honda, S; Jinzaki, M; Hirano, Y; Mitoma, R; Tamura, S; Baba, S; Togao, O; Kosaka, H; Okazawa, H; Kimura, Y; Mimura, M; Takahashi, T

    MOLECULAR PSYCHIATRY   30 ( 5 )   1780 - 1790   2025年5月   ISSN:1359-4184 eISSN:1476-5578

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/s41380-024-02785-1

    Web of Science

    PubMed

  • Successful Management of ECT-Resistant Interictal Psychosis With Clozapine A Case Report 査読 国際誌

    Mitoma, R; Hirano, S; Nakao, T

    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY   44 ( 5 )   527 - 528   2024年9月   ISSN:0271-0749 eISSN:1533-712X

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Clinical Psychopharmacology  

    DOI: 10.1097/JCP.0000000000001904

    Web of Science

    Scopus

    PubMed

  • Toward recovery in schizophrenia: Current concepts, findings, and future research directions 査読 国際誌

    Onitsuka, T; Hirano, Y; Nakazawa, T; Ichihashi, K; Miura, K; Inada, K; Mitoma, R; Yasui-Furukori, N; Hashimoto, R

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   76 ( 7 )   282 - 291   2022年7月   ISSN:1323-1316 eISSN:1440-1819

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Psychiatry and Clinical Neurosciences  

    Schizophrenia was initially defined as “dementia praecox” by E. Kraepelin, which implies progressive deterioration. However, recent studies have revealed that early effective intervention may lead to social and functional recovery in schizophrenia. In this review, we provide an overview of current concepts in schizophrenia and pathophysiological hypotheses. In addition, we present recent findings from clinical and basic research on schizophrenia. Recent neuroimaging and neurophysiological studies have consistently revealed specific biological differences in the structure and function of the brain in those with schizophrenia. From a basic research perspective, to determine the essential pathophysiology underlying schizophrenia, it is crucial that findings from all lines of inquiry—induced pluripotent stem cell (iPSC)-derived neural cells from patients, murine models expressing genetic mutations identified in patients, and patient clinical data—be integrated to contextualize the analysis results. However, the findings remain insufficient to serve as a diagnostic tool or a biomarker for predicting schizophrenia-related outcomes. Collaborations to conduct clinical research based on the patients' and their families' values are just beginning, and further development is expected.

    DOI: 10.1111/pcn.13342

    Web of Science

    Scopus

    PubMed

  • Oscillatory brain network changes after transcranial magnetic stimulation treatment in patients with major depressive disorder 査読 国際誌

    Mitoma R., Tamura S., Tateishi H., Mitsudo T., Tanabe I., Monji A., Hirano Y.

    Journal of Affective Disorders Reports   7   2022年1月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Affective Disorders Reports  

    Background:: Repetitive transcranial magnetic stimulation (rTMS) has attracted attention for treating treatment-resistant major depressive disorder (MDD) because of its effectiveness and low invasiveness. Recent neuroimaging studies suggest that the effects of rTMS in MDD may be based on improvements in abnormal brain networks. However, oscillatory network changes after rTMS remain unclear. This study aimed to detect oscillatory electroencephalography (EEG) markers that reflect the therapeutic effects of rTMS. Methods:: We treated 15 treatment-resistant MDD patients with high-frequency (10 Hz) rTMS over the left prefrontal cortex for 6 weeks. The power spectral density at each electrode and the phase lag index between all electrode pairs were compared before and after rTMS using clinical EEG data. The relationships between EEG indices, depressive symptoms, and cognitive function were also examined. Results:: Depressive symptoms were significantly improved after rTMS. Additionally, functional connectivity between the left frontal–temporal and occipital regions in the theta band and gamma power in the anterior–central area were increased in both hemispheres after rTMS. Increased functional connectivity in the theta band was correlated with improved cognitive function, while increased gamma power was correlated with worsened depressive symptoms. Limitations:: The sample size was relatively small. Conclusion:: Our results demonstrated oscillatory changes in theta-band functional connectivity after rTMS in MDD patients. These findings, obtained using clinical EEG methods, provide evidence of the underlying neurophysiological effects of rTMS on MDD within the context of functional brain network changes, and may constitute a biomarker for evaluating MDD treatments.

    DOI: 10.1016/j.jadr.2021.100277

    Scopus

▼全件表示

講演・口頭発表等

▼全件表示

MISC

  • てんかん患者に合併した精神病症状

    山田 亮, 三笘 良, 平野 昭吾, 平野 羊嗣, 中尾 智博

    九州神経精神医学   68 ( 3-4 )   107 - 107   2023年8月   ISSN:0023-6144

     詳細を見る

    記述言語:日本語   掲載種別:研究発表ペーパー・要旨(全国大会,その他学術会議)   出版者・発行元:九州精神神経学会  

  • 【脳画像研究により精神疾患はどこまでわかったか,そして今何をやるべきなのか】精神疾患の神経生理学的知見 統合失調症の神経振動異常を中心に

    三笘 良, 平野 羊嗣

    日本生物学的精神医学会誌   34 ( 1 )   30 - 37   2023年3月   ISSN:2186-6619

     詳細を見る

    担当区分:筆頭著者   記述言語:日本語   掲載種別:記事・総説・解説・論説等(学術雑誌)   出版者・発行元:日本生物学的精神医学会  

    統合失調症をはじめとした精神疾患では病態解明や介入手段の確立をめざして,各領域でさまざまなアプローチが試みられてきた。神経生理学研究においても数多くの指標に着目した報告があるが,なかでも神経振動は特に有望なバイオマーカーの候補と目されている。神経振動は脳内における興奮性と抑制性の伝達物質のバランスを基盤として,脳内情報伝達を担うリズミカルな皮質電気活動であり,統合失調症においても聴覚定常反応課題をはじめとして一貫性のある異常所見が得られている。また,ベースラインの自発振動と課題刺激で賦活された振動との間で十分な切り替えがなされないことも,計算論的神経科学の観点から説明が可能な統合失調症の特徴として指摘されている。神経振動は基礎と臨床を繋ぐトランスレーショナル・リサーチを可能にするだけでなく,今後は大規模データ解析によってもますます発展が見込まれている。(著者抄録)

専門診療領域

  • 生物系/医歯薬学/内科系臨床医学/精神神経科学

臨床医資格

  • 専門医

    日本てんかん学会

  • 指導医

    日本精神神経学会

  • 専門医

    日本精神神経学会

医師免許取得年

  • 2015年